drugset / Trial / NCT06046742
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
A Phase I Study of the Safety and Tolerability of M1-c6v1 Administered Via Intravenously for Treatment of Patients With Locally Advanced or Metastatic Solid Tumors
Timeline
- Start
- 2024-07-10
- Primary completion
- 2028-06-30
- Completion
- 2028-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | M1-c6v1 | Unknown | — | Intravenous |